Search research articles
Contact Us
Filters
Showing results (1251-1260 of 1,265) with videos related to
Page
of 127
Sort By:
The British Journal of Dermatology
|
November 13, 2018
Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation
D Bessis, J Miquel, E Bourrat, et al.
Nature Communications
|
July 25, 2023
Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19
Shelly J Robertson, Olivia Bedard, Kristin L McNally, et al.
The Lancet. HIV
|
March 6, 2025
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M Best, et al.
The Lancet. HIV
|
March 27, 2024
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Aditya H Gaur, Edmund V Capparelli, Katherine Calabrese, et al.
The Lancet. HIV
|
May 11, 2020
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
Esaú C João, R Leavitt Morrison, David E Shapiro, et al.
Applied and Environmental Microbiology
|
February 9, 2024
Genomic epidemiology of third-generation cephalosporin-resistant <i>Escherichia coli</i> from Argentinian pig and dairy farms reveals animal-specific patterns of co-resistance and resistance mechanisms
Oliver Mounsey, Laura Marchetti, Julián Parada, et al.
The Journal of Infectious Diseases
|
June 24, 2016
Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015
Emmie de Wit, Kyle Rosenke, Robert J Fischer, et al.
The Journal of Allergy and Clinical Immunology
|
October 25, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Bruce Zuraw, William R Lumry, Douglas T Johnston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 18, 2016
Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients
Kyle Rosenke, Jennifer Adjemian, Vincent J Munster, et al.
The Journal of Small Animal Practice
|
May 28, 2025
Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011-2021)
C D Prior, H Swales, A Kortum, et al.
Page
of 127
Search research articles
Search
Showing results (1251-1260 of 1,265) with videos related to
Sort By:
Page
of 127
The British Journal of Dermatology
|
November 13, 2018
Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation
D Bessis, J Miquel, E Bourrat, et al.
Nature Communications
|
July 25, 2023
Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19
Shelly J Robertson, Olivia Bedard, Kristin L McNally, et al.
The Lancet. HIV
|
March 6, 2025
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M Best, et al.
The Lancet. HIV
|
March 27, 2024
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Aditya H Gaur, Edmund V Capparelli, Katherine Calabrese, et al.
The Lancet. HIV
|
May 11, 2020
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
Esaú C João, R Leavitt Morrison, David E Shapiro, et al.
Applied and Environmental Microbiology
|
February 9, 2024
Genomic epidemiology of third-generation cephalosporin-resistant <i>Escherichia coli</i> from Argentinian pig and dairy farms reveals animal-specific patterns of co-resistance and resistance mechanisms
Oliver Mounsey, Laura Marchetti, Julián Parada, et al.
The Journal of Infectious Diseases
|
June 24, 2016
Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015
Emmie de Wit, Kyle Rosenke, Robert J Fischer, et al.
The Journal of Allergy and Clinical Immunology
|
October 25, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Bruce Zuraw, William R Lumry, Douglas T Johnston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 18, 2016
Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients
Kyle Rosenke, Jennifer Adjemian, Vincent J Munster, et al.
The Journal of Small Animal Practice
|
May 28, 2025
Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011-2021)
C D Prior, H Swales, A Kortum, et al.
Page
of 127